Longevity - CD BioSciences Longevity - CD BioSciences

Anti-Aging Drug Discovery Services

Preclinical Anti-Aging Drug Development

Custom Model Customization Services

Aging-Related Disease Research Services

Advanced anti-aging research laboratory with modern equipment
Cutting-edge lab environment for anti-aging drug discovery
Researcher performing cell culture for anti-aging efficacy testing

Your Trusted Partner in Anti-Aging Drug Development

CD BioSciences is a preclinical research service provider focused on the development of anti-aging drugs. With one-stop services spanning discovery, pharmacology, pharmacokinetics, and safety evaluation, we provide comprehensive support to help partners advance innovative anti-aging drug pipelines.

READ MORE
Anti-aging drug research and development

Anti-Aging Drug Discovery Services

Leveraging advanced platforms and extensive expertise, we provide customized solutions to support the discovery of anti-aging drugs across diverse targets and drug types.

By Target

AMPK

mTOR

SIRT1

NF-κB

p53

MDM2

BCL-2

FoxOs

AKT

PGC1α

PPARγ

CRTC

GD3

Wnt

IL-11

PI3K

JAK

…

By Drug Type

Senolytics

Senomorphics

Calorie Restriction Mimetics

Autophagy Inducers

Anti-Inflammatory Drugs

Antioxidants

Telomerase Activators

Mitochondrial Modulators

Protein Kinase Modulators

Epigenetic Drugs

Preclinical Anti-Aging Drug Development Services

Anti-Aging Pharmacology Services

CD BioSciences offers in vitro and in vivo anti-aging pharmacology services to help pharmaceutical companies in the development of anti-aging therapeutics.

Read More 01

In Vitro ADME Services

We provide in vitro ADME studies to evaluate pharmacokinetic behaviors early in the development pipeline, enabling the identification of candidates before advancing to development stages.

Read More 02

In Vivo Pharmacokinetic Services

We conduct preclinical PK studies to characterize bioavailability, half-life, and tissue distribution, providing essential data for dose optimization in anti-aging therapeutics.

Read More 03

In Vitro Toxicity Testing Services

We offer dermal toxicity, ocular irritation, and phototoxicity testing to assist clients in determining the toxic effects of anti-aging drugs.

Read More 04

Non-GLP Toxicology Services

We offer acute, subchronic and chronic toxicity studies, genetic toxicology testing, and carcinogenicity studies, to help clients evaluate the efficacy of anti-aging drugs.

Read More 05

Safety Pharmacology Services

We offer safety pharmacology services to evaluate potential effects of anti-aging drugs on key physiological systems, such as the cardiovascular, respiratory, and central nervous systems.

Read More 06

Custom Models for Preclinical Aging Research

CD BioSciences offers in vitro and in vivo aging model customization services to accelerate aging research, drug discovery, and anti-aging efficacy evaluation.

Aging Models

We have been dedicated to longevity research for years and offer longevity model customization services to unlock the secrets of extended lifespan.

Longevity Models

Our aging-related disease model customization services help clients study aging mechanisms, validate therapeutic targets, and evaluate the efficacy and safety of anti-aging drugs.

Aging-Related Disease Models

We provide a full suite of modeling and characterization services for organ-specific aging processes, generating reliable preclinical data for anti-aging drug development.

Organ-Specific Aging Models

Therapeutic Areas

By integrating advanced platforms and expertise, CD BioSciences supports the discovery and development of innovative anti-aging drugs across multiple therapeutic areas.

Aging-Related Neurodegenerative Disease R&D Services

Aging-Related Cardiovascular Disease R&D Services

Aging-Related Cancer R&D Services

Aging-Related Bone Disease R&D Services

Age-Related Macular Degeneration R&D Services

Age-Related Hearing Loss R&D Services

Aging-Related Sarcopenia R&D Services

Aging-Related Neurodegenerative Disease R&D Services

Neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis (ALS) associated with aging. CD BioSciences provides integrated research and preclinical development services to accelerate the discovery and development of drugs targeting aging-related neurodegeneration.

Aging-Related Cardiovascular Disease R&D Services

Cardiovascular diseases (CVDs) remain one of the leading causes of morbidity and mortality in aging populations. Our multidisciplinary expertise combines molecular biology, pharmacology, and physiology to support the discovery and development of novel drugs for aging-related cardiovascular disorders.

Aging-Related Cancer R&D Services

Aging is one of the strongest risk factors for cancer development, as the accumulation of DNA damage, cellular senescence, chronic inflammation, and impaired immune surveillance contribute to tumor initiation and progression. Our comprehensive services encompass from pathogenesis analysis, biomarker identification, and disease model customization, to drug discovery and development.

Aging-Related Bone Disease R&D Services

Aging leads to progressive deterioration in bone quality and remodeling capacity, resulting in increased susceptibility to osteoporosis, osteoarthritis, and other degenerative bone disorders. CD BioSciences provides comprehensive research and preclinical development services to support the development of therapeutics that restore bone homeostasis and slow skeletal aging.

Age-Related Macular Degeneration R&D Services

Age-related macular degeneration (AMD) is a leading cause of vision loss among the elderly. Our expertise spans cellular, molecular, and pharmacological approaches that support mechanism studies, target validation, and therapeutic evaluation across both dry (atrophic) and wet (neovascular) forms of AMD.

Age-Related Hearing Loss R&D Services

Age-related hearing loss (ARHL), also known as presbycusis, is one of the most prevalent sensory disorders among the elderly. Through investigating the underlying mechanisms of ARHL, our company aims to help clients identify potential targets and develop therapeutic strategies.

Aging-Related Sarcopenia R&D Services

Sarcopenia, characterized by the progressive loss of skeletal muscle mass, strength, and function, is a hallmark of aging and a major contributor to frailty and reduced quality of life in the elderly. We provide comprehensive services to accelerate sarcopenia drug development from target identification to preclinical validation.

Are You Ready? Contact Us Now!
Contact Us Now
QUICK LINK

Home

Therapeutic Areas

Custom Models for Preclinical Aging Research

Anti-Aging Drug Discovery

Preclinical Anti-Aging Drug Development

Pipeline

CONTACT US
facebook twitter linkedin

Copyright © 2025 CD BioSciences. All rights reserved.